The average tumour weight of MAMDC2‐expressing xenografts was ~62% of controls (P < .05; Figure 6C,D), indicating that the MAMDC2 expression can attenuate in vivo tumour cell proliferation. The gene discussed is MAMDC2; the disease is neoplasm.